Cargando…
The onset of PI3K‐related vascular malformations occurs during angiogenesis and is prevented by the AKT inhibitor miransertib
Low‐flow vascular malformations are congenital overgrowths composed of abnormal blood vessels potentially causing pain, bleeding and obstruction of different organs. These diseases are caused by oncogenic mutations in the endothelium, which result in overactivation of the PI3K/AKT pathway. Lack of r...
Autores principales: | Kobialka, Piotr, Sabata, Helena, Vilalta, Odena, Gouveia, Leonor, Angulo‐Urarte, Ana, Muixí, Laia, Zanoncello, Jasmina, Muñoz‐Aznar, Oscar, Olaciregui, Nagore G, Fanlo, Lucia, Esteve‐Codina, Anna, Lavarino, Cinzia, Javierre, Biola M, Celis, Veronica, Rovira, Carlota, López‐Fernández, Susana, Baselga, Eulàlia, Mora, Jaume, Castillo, Sandra D, Graupera, Mariona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260211/ https://www.ncbi.nlm.nih.gov/pubmed/35695059 http://dx.doi.org/10.15252/emmm.202115619 |
Ejemplares similares
-
Revisiting PI3-kinase signalling in angiogenesis
por: Kobialka, Piotr, et al.
Publicado: (2019) -
PI3K at the crossroads of tumor angiogenesis signaling pathways
por: Soler, Adriana, et al.
Publicado: (2015) -
Clinical report: one year of treatment of Proteus syndrome with miransertib (ARQ 092)
por: Biesecker, Leslie G., et al.
Publicado: (2020) -
Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania
por: Nandan, Devki, et al.
Publicado: (2018) -
Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility
por: Angulo-Urarte, Ana, et al.
Publicado: (2018)